Orofresh OS5%+1%

Orofresh OS is a topical combination preparation used for the removal of common warts, plantar warts, corns, and calluses through keratolytic (skin-softening/peeling) action.

Evidence-based use classification

• Established/well-supported use: Removal of common (verruca vulgaris) and plantar warts, and softening/removal of corns and calluses — this is the well-established indication for the salicylic acid component, supported by OTC drug monograph data and long clinical use.
• Adjunct/supportive component: The rhubarb extract component is traditionally included for its mild astringent and keratolytic-supportive properties; clinical evidence specifically demonstrating additional benefit of rhubarb extract on top of salicylic acid alone is limited, so it should be regarded as a supportive/traditional ingredient rather than an independently proven active.
• Not indicated for: Facial warts, genital or anal warts, warts on mucous membranes, moles, birthmarks, or warts with hair growing from them — these require physician evaluation and are not appropriate for self-treatment with Orofresh OS.

Rhubarb Extract + Salicylic Acid is a topical combination product containing:

• Salicylic Acid — a well-established keratolytic agent (typical strengths used in over-the-counter wart/corn preparations range from approximately 17% in flexible collodion-type solutions to 40% in plaster/pad form, depending on the specific product formulation).
• Rhubarb Extract — a botanical extract traditionally used for its astringent and mild keratolytic-supportive properties.

Exact concentrations vary by brand and formulation (solution, gel, or medicated pad); always check the product label for the specific strength dispensed.

Orofresh OS is a topical, non-prescription combination preparation formulated for localized application to skin lesions such as common warts, plantar warts, corns, and calluses. It works primarily through the keratolytic action of salicylic acid, which softens and gradually dissolves thickened, hyperkeratotic skin, supported by the traditional astringent properties of rhubarb extract.

It is intended strictly for external use on intact, non-facial, non-genital skin, and is not a systemic medication.

Topical Keratolytic Agent (Wart, Corn and Callus Removal Preparation)

Rhubarb Extract + Salicylic Acid acts locally on the skin surface:

• Salicylic acid is a keratolytic that works by dissolving the intercellular cement substance that binds keratinized skin cells together, causing the outer, hyperkeratotic (thickened) layer of skin to soften, swell, and eventually desquamate (peel away). Repeated application progressively thins the wart, corn, or callus tissue.
• Rhubarb extract contains tannins and anthraquinone derivatives that provide a mild astringent effect, traditionally believed to support tissue softening and have a mild antimicrobial/soothing action on the treated area, although robust comparative clinical trial data isolating its independent contribution are limited.

Systemic absorption is normally minimal when the product is used correctly over small, limited areas of intact skin, but absorption increases significantly with use on broken skin, large surface areas, or occlusive dressings.

For external (topical) use only. Apply Orofresh OS directly to the lesion using the applicator provided (brush, dropper, or pad) after soaking and drying the skin. Avoid contact with eyes, lips, mouth, mucous membranes, and normal surrounding skin. Wash hands thoroughly after application unless the hands themselves are being treated. Do not bandage tightly or use occlusive dressings unless specifically directed, as this increases systemic absorption and irritation risk.

Orofresh OS is applied topically and has minimal systemic absorption when used as directed, so clinically significant systemic drug interactions are uncommon. However:

• Other topical keratolytics/exfoliants (e.g., other salicylic acid products, retinoids, benzoyl peroxide, or alpha-hydroxy acid preparations) applied to the same or nearby skin area may cause additive irritation, excessive peeling, or skin breakdown; concurrent use on the same site should be avoided unless directed by a physician.
• Oral or systemic salicylates (e.g., high-dose aspirin) used concurrently with extensive topical salicylic acid application may increase the overall risk of salicylate toxicity due to cumulative systemic absorption — see Overdose Effects.

Most side effects of Orofresh OS are local reactions at the application site:

• Common: Mild burning, stinging, or tingling sensation on application; local redness; peeling or flaking of skin; dryness.
• Less common: Excessive irritation, blistering, or whitening/maceration of skin if left on too long or applied to too large an area.
• Rare but serious: Chemical burn or ulceration of skin with overuse; signs of salicylate toxicity (see Overdose Effects) with widespread or prolonged use, particularly in children or if used on large body surface areas.

Discontinue use and seek medical advice if excessive irritation, pain, or signs of infection develop.

There are no well-controlled clinical studies establishing the safety of Orofresh OS during pregnancy or breastfeeding. Systemic absorption from correctly limited topical use is expected to be minimal; however, Orofresh OS should be used during pregnancy only if clearly needed, on the smallest area necessary, and after consulting a physician, since the potential risk to the fetus from significant systemic salicylate absorption cannot be entirely excluded with extensive or prolonged use.

During breastfeeding, Orofresh OS should also be used only under medical advice, avoiding application to the chest/breast area, and limited to the smallest necessary area to minimize any potential systemic absorption.

• For external use only; not for oral, ophthalmic, or mucosal use.
• Avoid contact with eyes, lips, mouth, and mucous membranes; rinse thoroughly with water if accidental contact occurs.
• Protect healthy surrounding skin (e.g., with a ring of petroleum jelly) before application to reduce the risk of chemical irritation to normal skin.
• Limit the treated surface area and duration of use; do not apply to large body surface areas, since this increases the risk of significant salicylate absorption and systemic toxicity (see Overdose Effects), particularly in children.
• Discontinue use and consult a physician if excessive irritation, redness, swelling, or pain develops, or if the wart/corn does not improve within the timeframe stated on the product label.
• Use with caution, and only under professional guidance, in patients with diabetes mellitus or poor peripheral circulation, as keratolytic agents carry an increased risk of tissue injury and delayed healing in these patients.
• Evidence supporting an additional independent benefit from the rhubarb extract component beyond that of salicylic acid alone is limited; salicylic acid's keratolytic efficacy is well established, while rhubarb extract should be regarded as a traditional, supportive ingredient.

Overdose or excessive use of Orofresh OS — particularly application over large areas, use of occlusive dressings, prolonged use, or accidental ingestion — can lead to salicylate toxicity. Signs and symptoms may include ringing in the ears (tinnitus), nausea, vomiting, dizziness, rapid/deep breathing, confusion, or drowsiness.

If accidental ingestion occurs, or if any signs of salicylate toxicity appear, discontinue use immediately and seek immediate medical attention or contact a poison control center/emergency services without delay. Do not attempt unsupervised home treatment for suspected salicylate toxicity.

Store at room temperature (below 30°C), away from light, moisture, and open flame (some formulations use a flammable collodion-type base). Keep the container tightly closed and out of reach of children.

• Children: Use Orofresh OS in children only under adult supervision and as directed on the product label; children are at greater risk of salicylate toxicity from a given applied dose due to a higher body-surface-area-to-weight ratio. Consult a physician before use in young children (commonly, use is not recommended below the age specified on the product label, often around 2 years).
• Elderly: No specific dose adjustment established, but elderly patients with diabetes, poor circulation, or fragile skin should use only under medical supervision.
• Diabetes/peripheral vascular disease: Use only under professional guidance due to increased risk of skin injury and poor wound healing.
• Immunocompromised patients: Consult a physician before self-treating warts, as immune status affects wart persistence and healing.

Typically used once or twice daily for up to 12 weeks for wart treatment, and reassessed after 2 weeks for corns/calluses. If there is no visible improvement within the timeframe specified on the product label, or if the lesion worsens, treatment should be stopped and a physician consulted rather than continuing use indefinitely.

Keratolytic agents; Topical dermatological preparations; Wart, corn and callus remedies

The keratolytic effect of Rhubarb Extract + Salicylic Acid results mainly from salicylic acid, which disrupts the intercellular corneodesmosomal bonds in the stratum corneum, reducing corneocyte cohesion and promoting controlled desquamation of thickened, hyperkeratotic skin such as warts, corns, and calluses. This gradually reduces the bulk of the lesion with repeated application. Rhubarb extract contributes astringent tannins that are traditionally believed to firm and dry the treated tissue, supporting the peeling process, though its independent mechanistic contribution is less rigorously characterized than that of salicylic acid.

Orofresh OS may be used in children, but only under adult supervision and strictly according to the age restriction and directions stated on the specific product label, as many such preparations are not recommended for children below a certain age (commonly around 2 years) due to increased risk of skin irritation and salicylate toxicity from a comparatively larger applied-dose-to-body-size ratio. Application should be limited to the smallest necessary area, and a physician should be consulted before use on children with diabetes, poor circulation, or widespread lesions. Safety and efficacy of rhubarb extract specifically in pediatric populations have not been formally established.